Skip to main content
Hester Biosciences Ltd logo

Hester Biosciences Ltd — Investor Relations & Filings

Ticker · HESTERBIO ISIN · INE782E01017 LEI · 984500836B9EB1DC4935 BSE.NS Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2018-11-13 Proxy Solicitation & In…
Country IN India
Listing BSE.NS HESTERBIO

About Hester Biosciences Ltd

https://www.hester.in/

Hester Biosciences Ltd specializes in the development, manufacturing, and marketing of animal healthcare products. The company primarily focuses on two segments: poultry healthcare and livestock healthcare. Its extensive product portfolio includes a wide range of live and inactivated vaccines, as well as health products such as therapeutics, herbal supplements, and disinfectants. Hester is recognized for its significant contributions to global animal disease control programs, particularly in the eradication of Peste des Petits Ruminants (PPR) and Brucellosis. The company operates advanced manufacturing facilities and maintains a robust distribution network to serve domestic and international markets. By leveraging research and development, Hester provides diagnostic services and technical support to enhance animal productivity and welfare. Its commitment to quality and innovation has established it as a key provider of biologicals and health solutions for the veterinary sector.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice dated 13 November 2018 from Hester Biosciences Limited. It references the Companies Act, 2013, and SEBI regulations, and it details resolutions to be passed by members through postal ballot and e-voting. The key content includes proposals for issuance of equity shares through Qualified Institutional Placement or preferential allotment, continuation of a Non-Executive Director's term, and revision in remuneration of the CEO & Managing Director. The document is a notice calling for shareholder approval on these matters, not the results of the vote or the actual resolutions passed. It is not a full financial report, audit report, or earnings release. It is also not a proxy solicitation or voting results announcement but a notice for a postal ballot. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2018-11-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for Hester Biosciences Limited for Q2 and H1 FY2019, dated 29 October 2018. It includes management commentary on financial performance, sales growth, profitability, segment performance, geographic sales, financial ratios, and dividend declaration. The presence of a Q&A session and detailed financial discussion confirms it is a full transcript of the earnings call rather than a brief earnings release or summary. The document also includes a correction notice for the transcript, reinforcing that this is a call transcript. Therefore, the document fits the category of a Call Transcript (CT).
2018-11-01 English
Updates
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an official communication from Hester Biosciences Limited to stock exchanges regarding the intimation of a Postal Ballot. It outlines the proposal to conduct a postal ballot for shareholder approval on several special resolutions, including issuance of equity shares, continuation of a director's term, and revision of remuneration. The document includes a calendar of events for the postal ballot and e-voting process. It does not contain actual voting results or detailed financial data, nor is it a report or transcript. It is an announcement related to the voting process for shareholder approval. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) as it pertains to shareholder voting procedures and resolutions to be approved by members.
2018-10-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call held on 29 October 2018 discussing the unaudited standalone financial results for the quarter and half year ended 30 September 2018. It includes detailed management commentary on financial performance, sales growth, profitability, segment performance, and outlook, followed by a Q&A session. The presence of a moderator, analyst questions, and management responses confirms this is a full call transcript. The document length is substantial (15,000 characters), and it contains substantive financial data and analysis, not just a summary or announcement. Therefore, the document fits the definition of a Call Transcript (CT).
2018-10-31 English
Dividend
Regulatory Filings
2018-10-29 English
Record Date
Notice of Dividend Amount Classification · 100% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the fixing of a record date for an interim dividend payment. It references the SEBI Listing Obligations and Disclosure Requirements and specifies the dividend amount and record date. The content is an announcement about dividend details rather than a full report or financial statement. The document length is short (1017 characters), and it clearly states the dividend information, which fits the definition of a Notice of Dividend Amount (DIV).
2018-10-29 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.